Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Parkinson's disease Clinical Trials

A listing of Parkinson's disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (705) clinical trials

Subjects will be evaluated via both in-clinic and at-home assessments. The in-clinic assessments are designed to compare the ability of current Parkinson disease clinical trial measures with the ability of mobile and wearable devices to detect disease progression in the early stage of disease. The at-home assessments are designed to ...

Phase N/A

This is a pilot, hypothesis-generating study to explore the effects of pimavanserin and low-dose quetiapine in subjects with Parkinson's disease with neuropsychiatric symptoms.

Phase

Multicenter, randomized, double-blind, parallel-group, placebo-controlled, fixed-dosage, Phase 2a study comparing 3 dosages of LY3154207  

Phase

A Phase 1B, 2-Period, Open Label, Multicenter, Dose Escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06649751 in subjects with Parkinson’s disease and motor fluctuations.

Phase N/A

The purpose of this study is to see if selegiline and tadalafil (generic for Cialis®) results in an improvement in Erectile dysfunction (ED) in male patients with Parkinson's disease (PD) and moderate ED. Male PD patients who have an incomplete response to tadalafil alone will be given both medications to ...

Phase

This research study will assess the safety, tolerability and effectiveness of Accordion Pill Carbidopa/Levodopa (AP-CD/LD) compared to Immediate Release Carbidopa/Levodopa (IR CD/LD) (Sinemet) in patients with fluctuating Parkinson’s Disease (PD).

Phase N/A

Dr. Brad Racette will look at an investigational inhaler method for taking medication for Parkinson’s disease (PD). There are up to 7 outpatient office visits that will take 1 to 5 hours each. Participants will receive study drug or a placebo by an inhaler. Compensation is provided. Risks and benefits ...

Phase